{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:15:27Z","timestamp":1769606127067,"version":"3.49.0"},"reference-count":37,"publisher":"Tech Science Press","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2024.047893","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T07:36:13Z","timestamp":1719819373000},"page":"1575-1587","source":"Crossref","is-referenced-by-count":4,"title":["PD-1<sup>+<\/sup> and TIM-3<sup>+<\/sup> T cells widely express common \u03b3-chain cytokine receptors in multiple myeloma patients, and IL-2, IL-7, IL-15 stimulation up-regulates PD-1 and TIM-3 on T cells"],"prefix":"10.32604","volume":"32","author":[{"given":"EGOR V.","family":"BATOROV","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALISA D.","family":"INESHINA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATIANA A.","family":"ARISTOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VERA V.","family":"DENISOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SVETLANA A.","family":"SIZIKOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DARIA S.","family":"BATOROVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GALINA Y.","family":"USHAKOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EKATERINA Y.","family":"SHEVELA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELENA R.","family":"CHERNYKH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nature Reviews. Disease Primers"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13083","article-title":"Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival","volume":"101","author":"Turesson","year":"2018","journal-title":"European Journal of Haematology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase Ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"Journal of Clinical Oncology:"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1111\/bjh.15888","article-title":"Phase 1b trial of pembrolizumab monotherapy for relapsed\/refractory multiple myeloma: KEYNOTE-013","volume":"186","author":"Ribrag","year":"2019","journal-title":"British Journal of Haematology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/S2352-3026(19)30109-7","article-title":"Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): A randomised, open-label, phase 3 trial","volume":"6","author":"Usmani","year":"2019","journal-title":"The Lancet Haematology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2352-3026(19)30110-3","article-title":"Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): A randomised, open-label, phase 3 trial","volume":"6","author":"Mateos","year":"2019","journal-title":"The Lancet Haematology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"20846","DOI":"10.1038\/s41598-020-77941-y","article-title":"Quantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients","volume":"10","author":"Batorov","year":"2020","journal-title":"Scientific Reports"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.4049\/jimmunol.181.10.6738","article-title":"The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands","volume":"181","author":"Kinter","year":"2008","journal-title":"Journal of Immunology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.1102609","article-title":"Antigen-independent induction of TIM-3 expression on human T cells by the common \u03b3-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway","volume":"188","author":"Mujib","year":"2012","journal-title":"Journal of Immunology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/2159-8290.CD-19-0391","article-title":"Antitumor T-cell homeostatic activation is uncoupled from homeostatic inhibition by checkpoint blockade","volume":"9","author":"Marshall","year":"2019","journal-title":"Cancer Discovery"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"108093","DOI":"10.1016\/j.intimp.2021.108093","volume":"100","author":"Batorov","year":"2021","journal-title":"International Immunopharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3389\/fimmu.2019.01034","article-title":"Dynamics of expression of programmed cell death protein-1 (PD-1) on T cells after allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Simonetta","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2018-01-825240","article-title":"Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade","volume":"132","author":"Minnie","year":"2018","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/2326-6066.CIR-15-0055","article-title":"T-cell exhaustion in multiple myeloma relapse after autotransplant: Optimal timing of immunotherapy","volume":"4","author":"Chung","year":"2016","journal-title":"Cancer Immunology Research"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nature Reviews Immunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"636375","DOI":"10.3389\/fimmu.2021.636375","article-title":"Bystander memory T cells and IMiD\/checkpoint therapy in multiple myeloma: A dangerous tango?","volume":"12","author":"Sponaas","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/intimm\/dxm102","volume":"19","author":"Vranjkovic","year":"2007","journal-title":"International Immunology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Seminars in Immunology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.1100885","article-title":"B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients","volume":"187","author":"Schneider","year":"2011","journal-title":"Journal of Immunology"},{"key":"ref20","first-page":"25","article-title":"Emerging roles for IL-15 in the activation and function of T-cells during immune stimulation","volume":"2015","author":"Anthony","year":"2015","journal-title":"Research and Reports in Biology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1172\/JCI95914","volume":"128","author":"Mathews","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nature Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"Journal of Virology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLoS Pathogens"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13054-018-2305-5","volume":"23","author":"Mouillaux","year":"2019","journal-title":"Critical Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: Intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nature Reviews. Immunology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1364828","DOI":"10.1080\/2162402X.2017.1364828","article-title":"PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?","volume":"7","author":"Simon","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","volume":"6","author":"Intlekofer","year":"2005","journal-title":"Nature Immunology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-387664-5.00002-9","article-title":"Transcriptional control of natural killer cell development and function","volume":"109","author":"Hesslein","year":"2011","journal-title":"Advances in Immunology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"Kaech","year":"2012","journal-title":"Nature Reviews. Immunology"},{"key":"ref31","first-page":"e21549","article-title":"Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review","volume":"35","author":"Zhang","year":"2021","journal-title":"FASEB Journal:"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nature Reviews Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/eji.201847677","article-title":"Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation","volume":"49","author":"Mazzoni","year":"2019","journal-title":"European Journal of Immunology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/eji.201847722","article-title":"Eomesodermin controls a unique differentiation program in human IL-10 and IFN-\u03b3 coproducing regulatory T cells","volume":"49","author":"Gruarin","year":"2019","journal-title":"European Journal of Immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41375-021-01136-1","volume":"35","author":"Roessner","year":"2021","journal-title":"Leukemia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41586-022-05257-0","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41586-022-05192-0","volume":"610","author":"Codarri Deak","year":"2022","journal-title":"Nature"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-10\/OncolRes-32-10-47893\/OncolRes-32-47893.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:52:54Z","timestamp":1741312374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n10\/57953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.047893","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}